Company Data
Kiniksa Pharmaceuticals Ltd.
Ticker
KNSA
Current Price
$63.95 4.65%
Market Cap
$4.9B
Price Target
Refer to Report
Volume
712.3K
52wk Range
$26.27 - $67.53
Overview
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.